Do you know what your cancer drug is up to? Answering that question is not as simple as for medicines taken by well-defined patient groups, or principally for one disease. Yet among drug classes oncology treatments hold a unique position: A frightening disease of immense scientific interest, hundreds of pipeline drugs and nearly as many…
Generalized fears about taking medications are common among patients, according to a new study issued by Verilogue exploring the actual fears and concerns patients most frequently discuss in their doctors’ offices and how doctors respond to them. The review of 23,923 naturally occurring patient-doctor interactions across 14 specialties during the course of 18 months found…
The pharmaceutical sales force is undergoing a dra-matic evolution as the pharmaceutical industry shifts from pri-mary-care drugs to biotechnology and specialist medicines. To effectively promote this changing product mix, marketers must adapt their sales and marketing models. In particular, marketers need sales representatives with more clinical knowledge, patient focus, managed-care fluency, and understanding of territories.…
FDA is under new management. Margaret Hamburg, M.D., was sworn in to her position as FDA commissioner May 22, 2009, by Health and Human Services Secretary Kathleen Sebelius. Dr. Hamburg is an authority on global health,public health systems, infectious disease, bioterrorism, and emergency preparedness. She served as the Nuclear Threat Initiative’s founding VP for the…
Vaccines are anticipated to be one of the fastest-growing segments of the pharmaceutical market between 2008 and 2023. Analysts believe that new legislation, advancements in science, and enhanced vaccine awareness are contributing to vaccines growth, particularly in the United States. Recent growth of vaccines, such as sales of Merck & Co.’s blockbuster cervical cancer vaccine…
Don’t spend precious resources wooing early-stage investors. First build your business, then seek funding that can help you grow It’s the ongoing irony of early-stage investing: Just when your little-engine-that-could startup desperately needs funding, sophisticated investors have no interest in parting with their money. Not for a startup, not right now. But once your company…
FORT WASHINGTON, Pa, October 14, 2008 – Verilogue, a leading pharmaceutical market research firm that captures and analyzes authentic physician-patient interactions, will discuss the opportunities that exist to understand and shape customer attitudes and behaviors at the clinical point-of-practice. Specifically, Verilogue’s case study presentation at the Pharmaceutical Market Research Group (PMRG) Institute in Philadelphia later this…
FORT WASHINGTON, PA, October 13, 2008 – One of the biggest challenges facing primary care physicians treating patients with high cholesterol is getting patients to agree and adhere to recommended treatments, be they in the form of pharmaceutical therapy, lifestyle modifications, or a combination of each. At the annual American Academy of Communication in Healthcare (AACH…
Verilogue digitally records live interactions between patients and physicians and, once anonymized, the transcripts are provided to professionals and stude nts in the mental health discipline to enhance understanding of disease and treatment. Now, with this new agreement, database users will be able to research an additional 4,000 pages of content on topics such as…
New patient education and tools and technologies are helping to fill the monstrous gap in patient-physican communications.But even the best tools have to address the need for simple ,clear communication for both parties.PharmaVoice taps experts form all sides of the patient education specificatrum to find out what they believe make for the most effective interactions…